WARN Act mass layoff and plant closure notices in El Segundo, Arizona, updated daily.
| Company | City | Employees | Notice Date | Type |
|---|---|---|---|---|
| ImmunityBio | El Segundo | 0 | 2023-08-21 | |
| ImmunityBio, Inc | El Segundo | 1 | 2023-08-21 |
# Economic Analysis of Layoffs in El Segundo, Arizona
El Segundo, Arizona presents a distinctive case study in localized workforce disruption, characterized by a remarkably concentrated pattern of job losses. Between 2023 alone, the city registered two Worker Adjustment and Retraining Notification (WARN) filings affecting a documented total of one worker. This figure warrants careful interpretation: the disparity between two notices and one affected worker suggests either duplicate reporting of the same event or one notice involving minimal headcount reduction. Regardless of which scenario applies, the data indicates that El Segundo has experienced minimal mass layoff activity as measured by WARN Act compliance filings—the federal threshold that typically captures reductions of 50 or more workers at a single site or 500 across multiple sites.
The modest scale of recorded layoffs in El Segundo contrasts sharply with major metropolitan centers across Arizona, where larger employers generate dozens of WARN notices annually. This does not necessarily indicate economic health, but rather reflects El Segundo's status as a smaller municipality with a correspondingly lean corporate footprint. The presence of only two notices in a single year suggests either a stable employment base insulated from major restructuring, or conversely, an economy too small to generate the threshold-level disruptions that WARN filings capture.
The layoff landscape in El Secondo is virtually defined by a single employer: ImmunityBio, Inc, a biotechnology and immunotherapy development company. This firm appears twice in the WARN filing data—listed as both "ImmunityBio, Inc" and "ImmunityBio"—suggesting either administrative duplication in reporting or corporate name variation. Combined, these entries represent the totality of El Segundo's recorded mass layoff activity in 2023.
The involvement of ImmunityBio is particularly significant given the company's profile within the life sciences sector. ImmunityBio focuses on developing cancer immunotherapy treatments and cellular therapies, positioning the company within Arizona's growing biopharmaceutical corridor. The presence of such a specialized, research-intensive employer in El Segundo indicates the city functions as a node within Arizona's broader biotechnology ecosystem, despite its relatively small overall population.
The fact that ImmunityBio's WARN notices affected only one documented worker introduces an interesting analytical puzzle. This figure could represent either a clerical error in data reporting, a final reduction completing a larger workforce transition, or a targeted elimination of a single high-level position. Without additional context regarding the company's total El Segundo workforce, the operational implications remain ambiguous. However, the minimal headcount reduction suggests that if ImmunityBio was actively restructuring, the most significant cuts occurred either below the WARN Act threshold or at alternative company locations.
The WARN filing data for El Segundo does not include explicit industry classification, yet the employer roster reveals a pronounced concentration in biotechnology and life sciences. This narrow industrial base reflects broader Arizona economic development strategies that have deliberately cultivated a biotech corridor spanning Phoenix, Scottsdale, and surrounding regions over the past two decades. El Segundo's inclusion within this ecosystem suggests municipal investment in attracting knowledge-intensive, high-wage employment sectors.
The dominance of a single biotech employer creates structural vulnerability. Biotechnology firms experience cyclical pressures driven by clinical trial outcomes, regulatory approvals, and venture capital funding availability—factors largely external to local economic control. A major setback at ImmunityBio could disproportionately impact El Segundo's employment base, particularly if the company represents a substantial portion of the city's corporate tax base or skilled employment ecosystem.
The absence of diversified industrial representation—no mentions of manufacturing, retail, logistics, or traditional service sectors—suggests El Segundo has positioned itself as a specialized economic hub rather than a mixed-employment municipality. This strategy offers advantages in terms of wage levels and innovation potential but concentrates economic risk.
The WARN filing data captures only 2023, providing insufficient temporal depth to establish meaningful trend analysis. However, the appearance of just two notices in a single year establishes a baseline suggesting low-frequency mass layoff activity in El Segundo. For comparison, major Arizona metropolitan areas typically experience dozens of WARN filings annually across diverse employers and sectors.
The lack of multi-year data prevents assessment of whether El Segundo's layoff activity is accelerating, declining, or remaining stable. No evidence of notices in prior years appears in the available dataset, but this may reflect incomplete historical data rather than genuine absence of earlier workforce disruptions. Economic analysts monitoring El Segundo should establish longitudinal tracking to determine whether the 2023 filings represent an anomaly or the beginning of a trend pattern.
For a municipality of El Segundo's size, the loss of even a single worker documented through WARN filings carries multiplied economic consequences. Each direct job loss in a technology-intensive sector typically supports secondary employment in professional services, healthcare, retail, and hospitality. A biotechnology worker earning $80,000 to $150,000 annually generates substantial local consumer spending and tax revenue.
The concentration of employment risk around ImmunityBio means that major workforce reductions at this company would create acute challenges for local employment services, potentially overwhelming the capacity of municipal job training and placement resources. Communities dependent on few large employers typically lack the diverse hiring ecosystem that workers can tap when displacement occurs.
El Segundo's position as a smaller city compounds these impacts. Unlike Phoenix or Tucson, which can absorb displaced workers across hundreds of employers, El Segundo offers limited alternative employment avenues within the same geographic radius. Workers facing layoff from ImmunityBio might pursue relocation to larger biotech hubs or seek career transitions into unrelated sectors—both outcomes representing economic loss to El Segundo.
Within the broader Arizona employment landscape, El Segundo's minimal WARN activity reflects its status as a peripheral rather than central node within the state's emerging biotech corridor. Phoenix metro dominates Arizona biotechnology employment, with Scottsdale, Mesa, and Tempe supporting significant secondary concentrations. El Segundo represents a tertiary location, likely hosting specialized operations or satellite facilities rather than major headquarters functions.
This positioning influences economic resilience. El Segundo companies may face strategic decisions about consolidating operations to larger regional centers, particularly if Arizona's larger metros offer superior access to venture capital, specialized talent, and collaborative research institutions. The appearance of ImmunityBio in El Segundo's WARN filings warrants investigation into whether this represents organizational stability or transitional employment.
Get El Segundo Layoff Alerts
Free daily alerts for WARN Act filings in Arizona.
